SUN Pharmaceutical Industries Limited Tobramycin Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Tobramycin Export Records India — #2 Exporter, 77 Shipments, $3.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Tobramycin

India Pharmaceutical Trade Intelligence

$39.2M283 Suppliers134 CountriesHS 30049099

ExportsIndia → UNITED STATES62.3%India → RUSSIA15.3%

ImportsUNITED STATES → India$498.0K CHINA → India$88.3K

#1 Supplier: MANKIND PHARMA #1 Buyer: LIFESTAR PHARMA

SUN Pharmaceutical Industries Limited — Tobramycin Exporter #2 | $3.9M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Tobramycin Exporter Profile

Indian Pharmaceutical Exporter · #2 for Tobramycin · $3.9M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #2 Indian exporter of Tobramycin with $3.9M in export value and 77 verified shipments. SUN Pharmaceutical Industries Limited holds a 9.8% market share in Tobramycin exports across 4 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Tobramycin Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Tobramycin export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Tobramycin?

Country	Value	Shipments	Share
BELGIUM	$2.4M	62	63.2%
UNITED STATES	$1.0M	23	28.1%
AUSTRALIA	$300.0K	6	8.1%
RUSSIA	$25.5K	2

Who Are the Top Buyers of Tobramycin from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$1.8M	47
YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN	BELGIUM	$595.8K	15
SUN PHARMACEUTICAL INDUSTRIES,INC.	UNITED STATES	$534.8K	11
SUN PHARMA ANZ PTY LTD	AUSTRALIA	$300.0K	6
SUN PHARMACEUTICAL INDUSTRIES INC	UNITED STATES	$250.0K	5
SUN PHARMACEUTICAL INDUSTRIES, INC.	UNITED STATES	$169.6K	4
SUN PHARMACEUTICAL INDUSTRIES,INC,	UNITED STATES	$50.0K	1
SUN PHARMACEUTICAL INDUSTRIESINC.	UNITED STATES	$41.6K	2
AO "RANBAXY"	RUSSIA	$17.4K	1
AO RANBAXY -	RUSSIA	$8.1K	1

SUN Pharmaceutical Industries Limited supplies Tobramycin to 10 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN (BELGIUM) and SUN PHARMACEUTICAL INDUSTRIES,INC. (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Tobramycin Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
TOBRAMYCIN SUN 300MG/5MLNEBULIZER SOLUTI	$641.4K	18
TOBRAMYCIN SUN 300MG/5ML NEBULIZER SOLUT	$289.3K	8
TOBRAMYCIN SUN 300MG/5ML NEBULIZER SOLUTION TOBRAMYCIN 300MG/5ML NEBULISER SOLUTION [351 PACK X 4 X 14 = 19656 NOS]	$269.7K	6
Tobramycin Inhalation Solution USP, 300	$200.0K	4
TOBRAMYCIN INHALATION SOLUTION USP 300	$200.0K	4
TOBRAMYCIN SUN 300MG/5ML NEBULIZER SOLUTION TOBRAMYCIN 300MG/5ML NEBULISER SOLUTION [475 PACK X 4 X 14 = 26600 NOS]	$150.0K	3
TOBRAMYCIN SUN 300MG/5ML SOLUTION FOR INHALATION (TOBRAMYCIN 300MG/5ML NEBULISERSOLUTION) [1000 PACK X 4X14 =56000 NOS]NOS	$150.0K	3
TOBRAMYCIN INHALATION SOLUTION USP, 300MG/5 ML PACK : 04*14 BATCH : BAE0386A/BAE0378A MFD : 30.11.2023/28.11.2023 EXP :NOS	$149.4K	3
TOBRAMYCIN INHALATION SOLUTION USP,300 M	$100.0K	2
TOBRAMYCIN SUN 300MG/5MLNEBULIZER SOLUTION (FOR FRANCE) / TOBRAMYCIN 300 MG/5 MLNEBULISER SOLUTION BP (For EU) PACK: 04	$100.0K	2

SUN Pharmaceutical Industries Limited exports 41 distinct Tobramycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TOBRAMYCIN SUN 300MG/5MLNEBULIZER SOLUTI with 18 shipments worth $641.4K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Tobramycin Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MANKIND PHARMA LIMITED	$3.9M	78	2	$50.0K
2	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$3.9M	77	4	$50.0K
3	SENTISS PHARMA PRIVATE LIMITED	$3.0M	60	1	$50.0K
5	MYLAN LABORATORIES LIMITED	$2.3M	45	2	$50.0K

SUN Pharmaceutical Industries Limited ranks #2 among 283 Indian Tobramycin exporters. Average shipment value of $50.0K compared to the market average of $73.4K. The closest competitors by value are MANKIND PHARMA LIMITED and SENTISS PHARMA PRIVATE LIMITED.

Which Indian Ports Ship Tobramycin Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	454	17.0%
SAHAR AIR CARGO ACC (INBOM4)	329	12.3%
DELHI AIR	316	11.8%
SAHAR AIR	298	11.1%
NHAVA SHEVA SEA (INNSA1)	93	3.5%
CHENNAI AIR CARGO ACC (INMAA4)	88	3.3%
Delhi Air	86	3.2%
Bombay Air	79	3.0%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Tobramycin Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Tobramycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 93 individual customs records matching SUN Pharmaceutical Industries Limited exporting Tobramycin, covering 41 formulations to 4 countries via 10 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 134+ countries, 580+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Tobramycin

Tobramycin

SUN Pharmaceutical Industries Limited — Tobramycin Exporter Profile

SUN Pharmaceutical Industries Limited — Tobramycin Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Tobramycin?

Who Are the Top Buyers of Tobramycin from SUN Pharmaceutical Industries Limited?

What Is India's Total Tobramycin Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Tobramycin Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Tobramycin Exporters?

What Tobramycin Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Tobramycin to Key Markets

United States — FDA

Australia — TGA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Tobramycin Exporters?

Which Indian Ports Ship Tobramycin Exports?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Tobramycin Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Tobramycin Export Data from SUN Pharmaceutical Industries Limited

Tobramycin Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source